Form 8-K - Current report:
SEC Accession No. 0001193125-25-123707
Filing Date
2025-05-21
Accepted
2025-05-21 09:24:25
Documents
14
Period of Report
2025-05-21
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d13977d8k.htm   iXBRL 8-K 49108
2 EX-3.1 d13977dex31.htm EX-3.1 23662
3 EX-3.2 d13977dex32.htm EX-3.2 135909
  Complete submission text file 0001193125-25-123707.txt   375562

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA slrn-20250521.xsd EX-101.SCH 2841
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE slrn-20250521_lab.xml EX-101.LAB 18723
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slrn-20250521_pre.xml EX-101.PRE 11698
16 EXTRACTED XBRL INSTANCE DOCUMENT d13977d8k_htm.xml XML 3840
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-456-4393
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

EIN.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41696 | Film No.: 25971089
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)